During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Hepatitis C virus (HCV) infected patients are known to be at risk of developing liver
complications ie cirrhosis and liver cancer. However, the risks of morbidity and mortality are …

Hepatitis C virus (HCV) infection is considered a systemic disease because of involvement
of other organs and tissues concomitantly with liver disease. Among the extrahepatic …

Hepatitis C virus (HCV) has been shown to affect many tissues other than liver. However, of
the many extrahepatic manifestations (EMs) that have been associated with HCV, including …

In addition to its effects in the liver, chronic hepatitis C virus (HCV) infection can have serious
consequences for other organ systems. Extrahepatic manifestations include mixed …

An association between hepatitis C virus infection and neuropsychiatric symptoms has been
proposed for some years. A variety of studies have been undertaken to assess the nature …

Since its identification in 1989, hepatitis C virus (HCV) has emerged as a worldwide health
problem with roughly 185 million chronic infections, representing individuals at high risk of …

Infection with HCV leads to an array of symptoms that compromise health‐related quality of
life (HRQL). Chronic hepatitis C is treated primarily with pegylated interferon (peg‐IFN) and …

Chronic infection with hepatitis C virus (HCV) is associated with a wide spectrum of
extrahepatic manifestations, affecting different organ systems. Neurological complications …

The hepatitis C virus (HCV) is a common blood-borne illness that affects up to 2% of the
world's population and almost 4 million Americans. Cognitive impairment, or difficulty with …